Literature DB >> 29555225

Employing Irritable Bowel Syndrome Patient-Reported Outcomes in the Clinical Trenches.

Christopher V Almario1, Brennan M R Spiegel2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29555225     DOI: 10.1016/j.cgh.2017.12.026

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  5 in total

1.  The Impact of Diagnostic Status on Quality of Life in Irritable Bowel Syndrome.

Authors:  Gillian Eleanor Cassar; George Youssef J; Simon R Knowles; Richard Moulding; David Austin
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.555

2.  Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System.

Authors:  Eric D Shah; Darren M Brenner; Vincent L Chen
Journal:  Dig Dis Sci       Date:  2021-03-29       Impact factor: 3.199

Review 3.  Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders.

Authors:  Amol Sharma; Satish S C Rao; Kimberly Kearns; Kimberly D Orleck; Scott A Waldman
Journal:  Aliment Pharmacol Ther       Date:  2021-04-28       Impact factor: 8.171

4.  Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial.

Authors:  Shino Kikuchi; Yuki Oe; Yohei Sasaki; Hirono Ishii; Yuri Ito; Masaru Horikoshi; Takashi Sozu; Hiroshi Seno; Toshi A Furukawa
Journal:  BMC Gastroenterol       Date:  2020-02-04       Impact factor: 3.067

Review 5.  A Systematic Review of the Development and Psychometric Properties of Constipation-Related Patient-Reported Outcome Measures: Opportunities for Digital Health.

Authors:  V Vien Lee; Ni Yin Lau; David J Y Xi; Anh T L Truong; Agata Blasiak; Kewin T H Siah; Dean Ho
Journal:  J Neurogastroenterol Motil       Date:  2022-06-20       Impact factor: 4.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.